OFI Invest Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6M Hold
547,881
– – 0.34% 69
2026
Q1
$24.2M Buy
547,881
+547,583
+183,753% +$25.5M 0.32% 80
2025
Q4
$7.48K Hold
298
– – ﹤0.01% 370
2025
Q3
$6.55K Hold
298
– – ﹤0.01% 299
2025
Q2
$7K Sell
298
-284
-49% -$7.48K ﹤0.01% 313
2025
Q1
$15.3K Sell
582
-611
-51% -$21.7K ﹤0.01% 361
2024
Q4
$47.9K Buy
+1,193
New +$57K ﹤0.01% 289
2024
Q2
$132K Buy
1,193
+83
+7% +$10.5K ﹤0.01% 267
2024
Q1
$110K Hold
1,110
– – ﹤0.01% 166
2023
Q4
$99.9K Hold
1,110
– – ﹤0.01% 163
2023
Q3
$108K Sell
1,110
-133,546
-99% -$14.9M ﹤0.01% 136
2023
Q2
$16.3M Sell
134,656
-5,000
-4% -$667K 0.65% 53
2023
Q1
$21.4M Buy
+139,656
New +$23M 0.91% 45

Other funds holding MRNA

OFI Invest Asset Management's MRNA Position: Q2 2026 in Review

OFI Invest Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 547,881 shares worth $33.6M. The position accounts for 0.34% of the portfolio, ranked #69.

OFI Invest Asset Management first reported a position in MRNA in Q1 2023 and has held it in 13 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • OFI Invest Asset Management held 547,881 shares of Moderna worth $33.6M as of Q2 2026.
  • OFI Invest Asset Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.34% of OFI Invest Asset Management's portfolio in Q2 2026, its #69 holding.
  • OFI Invest Asset Management first reported a position in Moderna in Q1 2023 and has held it in 13 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.